Legendary Investor: Buy These "Trump Stocks" Now
Within the first week of Trump's election, several stocks exploded for double- and triple-digit gains. According to legendary investor Louis Navellier, this is just the beginning of what could be the best four-year period for stocks in U.S. history.
Ozempic Receives FDA Approval To Treat Kidney Disease
The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease in patients who also have type 2 diabetes.
Ontario leader calls for snap election to fight Trump's threatened tariffs
VANCOUVER, British Columbia (AP) — The leader of Ontario, Canada’s most populous province, on Wednesday triggered a snap election, saying he needs a strong four-year mandate to fight the .
The DOGE Agenda (Eight Stocks to Buy) - Ad
Every investor in America is trying to figure out what Musk will do in Washington, D.C. in the coming weeks.
Trump White House Blames 'Outage' For Medicaid Website Lockout: 'We Have Confirmed No Payments Have Been Affected'
On Tuesday January 28, 2025, a federal health payment system lockout, blamed on an "outage," sparked criticism amid Trump's spending freeze, though payments were reportedly unaffected, according to the white house.
Spotify Co-Founder Daniel Ek's Neko Health Secures $260 Million For US Expansion As It Compares Itself With 'The Apples Or Teslas Of The World'
Spotify co-founder Daniel Ek's health tech startup, Neko Health, raised $260 million to expand into the U.S., positioning itself alongside "Apples or Teslas" with its cutting-edge body scanning technology and a $1.7 billion valuation.
The $20 Stock Powering NVIDIA, TESLA, and Microsoft - Ad
The biggest AI firms in the world... All rely on this single company. And right now, you can get in for only $20 - but not for long.
UNC and Duke Health will build North Carolina's first standalone children's hospital
RALEIGH, N.C. (AP) — Two North Carolina-based university health systems plan to construct the state's first standalone children's hospital — an undertaking that its boosters said will change lives physically and economically for decades to come.
AbbVie Builds Momentum With Immunology Growth, Goldman Remains Positive
AbbVie plans to release Q4 2024 results on Jan. 31. Analysts predict $14.8 billion in sales, $2.10 EPS. Immunology growth remains a key focus for investors.
Elon's Next Millionaire-Making Project? - Ad
This could create more wealth than all of his previous ventures... combined.
Novo Nordisk's Weekly Amycretin Delivers Up to 22% Weight Loss in Study, Stock Soars
Novo Nordisk's amycretin trial results highlight significant weight loss in adults with obesity, with further clinical development planned.
Tips on overcoming the loss of cherished, personal belongings in disasters
Losing important sentimental belongings -- those items that represented who you are -- can be traumatic for those who that destroy homes. Some tips on how to get through it, emotionally and practically:
Do NOT Buy Nvidia, Apple, Microsoft, Meta, Tesla, or ANY Major Tech Stock... - Ad
31 billionaires (including: Warren Buffett, Elon Musk, Jeff Bezos, and more) are quietly unloading shares of their OWN stocks at RECORD pace... But why? Wall Street legend Eric Fry says it's because, soon: "America's most popular stocks like Nvidia, Apple, Meta, Tesla, and thousands more... are set to come plummeting back to Earth." Erasing YEARS of investor profits... Sparking a $17 trillion PANIC on Wall Street...
BrightSpring Health Divests Community Living Business For $850 Million To Focus On Core Activities
BrightSpring will sell its Community Living business to Sevita for $835M in a deal set to close in 2025, boosting operational focus and revenue growth projections.
Thomas Tighe reflects on 24 years leading the international health nonprofit Direct Relief
SANTA BARBARA, Calif (AP) — Just days before ending his 24-year tenure as president and CEO of Direct Relief, Thomas Tighe was still so energized talking about delivering free medications to people who couldn't afford them that he seemed to forget he was standing inside an enormous “cold room,” set to a crisp 39 degrees Fahrenheit (4 degrees Celsius).
He Called Every Bull And Bear Market In Crypto Since 2012 ... Here's What He Says Is Next - Ad
Juan Villaverde may be America's top crypto expert. According to Juan's timing model, we are entering what could be the biggest bull market in crypto's history. With America's first crypto president in office, it could be the biggest gains the market has ever seen. And one special coin could skyrocket.
Ozempic, Wegovy and other drugs are among 15 selected for Medicare's price negotiations
WASHINGTON (AP) — Popular weight loss drugs like have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said Friday.
Proposed rules would require nutrition info, allergen warnings on alcohol labels
Labels on wine, distilled spirits and malt beverages in the U.S. would be required to list alcohol content and nutritional information per serving, plus notification of potential allergens, under two new rules proposed Thursday by the Treasury Department.
AI's NEXT Magnificent Seven - Ad
The original Magnificent Seven produced 16,894% average returns over 20 years. But the man who called Nvidia at $1.10 says "AI's next Magnificent Seven could do it even faster." See his breakdown of the seven stocks you should own here.
UnitedHealth Q4 Earnings: Revenue Falls Short, Medical Ratio Rises To 85.5%, Stock Falls
UnitedHealth Group posted mixed Q4 results, with EPS beating estimates and revenue falling short. The company reaffirmed its 2025 guidance.
UnitedHealth books better-than-expected fourth-quarter profit
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt.
He Called Bitcoin to $100k... Now He Says This Coin Is Next - Ad
Juan Villaverde may be America's top crypto expert. According to Juan's timing model, we are entering what could be the biggest bull market in crypto's history. With America's first crypto president in office, it could be the biggest gains the market has ever seen. And one special coin could skyrocket.
FDA floats plan to make cigarettes nonaddictive, but its fate rests with Trump
WASHINGTON (AP) — Federal officials on Wednesday released a far-reaching proposal to by capping their , a goal long sought by antismoking advocates that is unlikely to go into effect anytime soon.
How Biden's domestic policy record stacks up against public perception
WASHINGTON (AP) — President ends his term with a gulf between his policy record and his public reputation.
Elon Musk: "AI Will Run Out of Electricity ... in 2025" - Ad
This AI boom is going to push America's power grid to the brink... Elon Musk even recently said that AI could run out of electricity by 2025. This crisis may just reveal one of the greatest investment ideas we are ever going to find. My research has recently uncovered two companies that could make a massive difference today.
Elon Musk says a third patient got a Neuralink brain implant. The work is part of a booming field
Elon Musk said a third person has from his brain-computer interface , one of many groups
J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies.
FORGET Crypto, FORGET Stocks... Do THIS Instead... - Ad
With everyone scrambling for the next hot AI stock or cryptocurrency... One man is saying FORGET them all. Because his strategy could lead to bigger gains than you'd see from stocks, crypto or anything else you might be seeing. It's shown his readers gains of 85% in 14 days... 55% gains in 2 days... And even 222% in 8 days!
Why Is Neuromuscular-Focused Dyne Therapeutics Stock Trading Lower On Friday?
Dyne Therapeutics' DYNE-101 shows promising Phase 1/2 results for myotonic dystrophy type 1, with plans for Accelerated Approval by 2026.
Why Is Intellia Therapeutics Stock Trading Lower On Friday?
Intellia Therapeutics prioritizes late-stage gene-editing programs for HAE and ATTR amyloidosis in 2025, announces leadership changes, and prepares for commercialization.
Is Artificial Intelligence the Biggest Bubble in History? - Ad
Is it any surprise 31 billionaires (including: Warren Buffett, Elon Musk, Jeff Bezos, and more) are quietly unloading their OWN stocks at record pace? They're getting OUT of AI (and Tech Stocks) before it's too late. But why? And WHERE are they moving their cash for the biggest profits, in 2025?
The 'Worst in Show' CES products put your data at risk and cause waste, privacy advocates say
LAS VEGAS (AP) — So much of the technology showcased at CES includes gadgets made to improve consumers' lives — whether by leveraging AI to make devices that help people become more efficient, by creating companions to cure loneliness or by providing tools that help people with mental and physical health.
Why Is Accolade Stock Trading Over 100% On Tuesday?
Transcarent to acquire Accolade Inc. for $7.03 per share, combining AI-driven care solutions with personalized healthcare expertise. Deal closes Q2 2025.
Seven Unknown AI Stocks That Could Dominate the Next Six Years - Ad
The original "Magnificent Seven" stocks generated 16,800% over the last 20 years. But now a new set of AI stocks is set to take over. Alex Green dubs them "The Next Magnificent Seven." And he's arguing that just $1,000 in each could turn into more than $1 million in less than six years.
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a growing global reach.
2 Indian companies charged with smuggling chemicals used in making fentanyl
NEW YORK (AP) — Two pharmaceutical companies based in India were charged Monday with smuggling chemicals used in the production of the deadly drug fentanyl, federal prosecutors in New York announced.
Critical Metals: The Linchpin of the Energy Transition - Ad
As EVs and AI take center stage, critical metals like copper, nickel, and PGMs are becoming the linchpin of clean energy and technological advances. One Canadian company's high-grade polymetallic discovery in Quebec is drawing comparisons to Russia's Norilsk Mine--one of the richest deposits globally. Backed by industry titans, this story is just beginning.
US Chamber, oil industry sue Vermont over law requiring companies to pay for climate change damage
The U.S. Chamber of Commerce and a top oil and gas industry trade group are requiring that fossil fuel companies pay a share of the damage caused over several decades by climate change.
Elevation Oncology: Promising Cancer Therapies Earn Analyst Praise
Elevation Oncology's ADCs target CLDN18.2 and HER3, with EO-3021 showing promising Phase 1 results and a $6.6 billion TAM in gastric and pancreatic cancers.
The Next Nvidia? - Ad
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.